Sustainability report

Supply chain management

Edwards Lifesciences’ supply chain management practices focus on product lifecycle, design and innovation, and product stewardship, supporting our aspiration of transforming patient lives with breakthrough medical technologies.


Monitoring and assessing the product quality, safety, social and environmental performance of Edwards’ suppliers, and maintaining responsible procurement practices.

Our aspirations


Passionate engagement that strengthens our communities


Excelling as a trusted partner through distinguished quality and integrity

Material topics
Highlight story

Edwards Sets Carbon Neutrality Target

As we pursue our patient-focused innovation strategy, Edwards understands the importance of addressing climate change and is committed to driving a meaningful reduction in our greenhouse gas (GHG) emissions.  In early 2022, Edwards set a new target to achieve carbon neutrality by the year 2030 and a commitment to set and achieve SBTi-recognized reduction targets for both our Scope 1/2 and Scope 3 GHG emissions.

As part of our commitment to achieve carbon neutrality by 2030, we plan to transition the majority of our global electricity demand to renewable sources over the course of the next seven years through a variety of methods, including onsite and offsite renewable energy generation.

We intend to establish a science-based target with SBTi in line with a 1.5°C scenario and are currently engaged with SBTi for approval on specific reduction targets for GHG emissions from our Scope 1 & 2 direct operations and Scope 3 value stream.

1Includes commitment to set and achieve SBTi-recognized Scope 1/2 and Scope 3 science-based targets
Highlight story

2021 Edwards Annual Supplier Partner Forum

At its annual Partner Forum, Global Supply Chain hosted key and strategic suppliers for information sharing and networking and to hear about current and upcoming business priorities at Edwards. Awards were also presented to suppliers based on performance.

The Partner Forum topics included updates from each of the Edwards Business Unit’s R&D departments including live demonstrations of our new products. There was a Listening Session where a patient talked about her experience before and after receiving an Edwards valve replacement. Suppliers who directly contributed to the patient’s implant were invited on stage. There were also presentations discussing planned initiatives for 2022 and our expectations of suppliers for the year.

After the Forum, supplier feedback expressed excitement about the direction Edwards is heading and clear expectations on how each can contribute to raising the bar going forward.

Highlight story

New Ireland Manufacturing Facility LEED Gold Certified

In 2021, Edwards opened its newest manufacturing plant in Limerick, Ireland.  The facility operates on 100% renewable electricity, primarily from wind energy, and is Edward’s first LEED Gold certified, carbon neutral, and zero waste-to-landfill manufacturing plant, and Ireland’s first medical device manufacturing plant to achieve LEED Gold V4 certification.

The new Ireland plant combines innovative design with critical functionality and features obstacle-free clean rooms and recreational spaces for our employees to enjoy. The building has capacity for three ISO 7 clean rooms, laboratories, a cafeteria, gym, and external athletic courts.

We continued our extensive expansion to our Irvine headquarters during 2021, including the completion of our new LEED Platinum Entry Pavilion, LEED Gold Dream Big Complex, and LEED Gold Café & Conference Center. LEED, which stands for Leadership in Energy and Environmental Design, is the most widely used green building rating system in the world and provides a framework for healthy, highly efficient, and cost-saving green buildings.